Global DNA Vaccines Market Research Report 2026(Status and Outlook)
DNA vaccines are vaccines that use recombinant DNA technology, introducing plasmids or other DNA vectors encoding specific antigens of a pathogen into the host organism, where host cells transcribe and translate the antigen, thus eliciting a specific immune response. Compared to traditional inactivated or attenuated vaccines, DNA vaccines offer flexibility in design, shorter production cycles, relatively high safety, and no risk of transmission of the complete pathogen. They are particularly promising in prevention of infectious diseases, tumor immunotherapy, and rapid response to public health threats, thanks to their capability for rapid customization, large-scale production, and comparatively easier storage, making them a key focus for global biopharma companies, governments, and research institutions.Amid growing global public health needs, frequent emergence of infectious disease variants, rising cancer incidence, and escalating antimicrobial resistance, DNA vaccines are increasingly viewed as core next-generation vaccine and immunotherapy solutions. Governments and international agencies have significantly increased funding for research targeting emerging pathogens (such as coronaviruses, malaria, dengue etc.), thereby providing continuous policy and financial support for DNA vaccine projects. At the same time, leaps in synthetic biology, gene synthesis, plasmid design and immunogenicity optimization have shortened timelines from lab validation to clinical stages, reducing failure costs. In clinical trials, multiple DNA vaccine candidates have shown positive safety profiles and immune responses (including T cell responses), boosting the confidence of markets and investors. Moreover, demand in the animal health / veterinary vaccine sector continues to accelerate, as viral and parasitic diseases exact heavy losses in livestock/aquaculture, and DNA vaccines? advantages in cold chain and transport make them particularly appealing, making those markets important early commercial footholds. Market valuation forecasts suggest the DNA vaccine industry will grow at a roughly 6-7% compound annual growth rate over the next decade, with market size likely to double, yielding large profit potential along the entire chain?from R&D through manufacturing and distribution.However, for DNA vaccines to become mainstream there are substantial challenges. First is immunogenicity: the strength and durability of immune responses in humans, especially relative to protein-based or viral vector vaccines, remain uncertain; some candidates in early trials have not elicited sufficiently high neutralizing antibodies or lasting T cell responses. Second, regulatory approval processes are stringent; different jurisdictions impose very cautious requirements about safety, long-term effects, gene insertion risks, etc., which may lengthen time to market and raise costs. Third, cost and production complexity are high, particularly in plasmid production, purification, delivery systems, and storage/transport (including cold or semi-cold chain) steps. High standard GMP facilities and rigorous quality control are essential; any lapse can impact stability and safety. Fourth, market education and acceptance: medical practitioners, patients, and public health bodies are still learning; uncertainty around side effects or long-term outcomes may fuel hesitancy and reduce uptake.Downstream, preventive applications (for infectious diseases) remain the dominant demand, especially in regions with frequent outbreaks or under-served by existing vaccine supply. Post-COVID-19, prime-boost regimens, booster shots, and heterologous immunization strategies are giving DNA vaccines renewed interest as stable, rapidly producible complements. Therapeutic applications are growing fast: cancer vaccines, chronic viral infections (e.g. HIV, HBV/HCV), parasitic/fungal disease vaccines are under clinical or early stage research. In the veterinary sector, demand is robust in poultry, aquaculture, and livestock for DNA vaccines that reduce disease losses, antibiotic use, and enhance yield. Public health bodies and government purchasers increasingly focus on total life-cycle cost: transportation & storage infrastructure, dose volume, durability, breadth of immune coverage?all of which amplify the attractiveness of DNA vaccines that are stable, require fewer doses, and have broad immune responses.
The global DNA Vaccines market size was estimated at USD 5378.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global DNA Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global DNA Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the DNA Vaccines market.
Global DNA Vaccines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Market Segmentation (by Type)
Recombinant Protein Vaccine
Gene-Based Vaccine
Market Segmentation (by Application)
Human
Animal
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the DNA Vaccines Market
Overview of the regional outlook of the DNA Vaccines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the DNA Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of DNA Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global DNA Vaccines market size was estimated at USD 5378.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global DNA Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global DNA Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the DNA Vaccines market.
Global DNA Vaccines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Market Segmentation (by Type)
Recombinant Protein Vaccine
Gene-Based Vaccine
Market Segmentation (by Application)
Human
Animal
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the DNA Vaccines Market
Overview of the regional outlook of the DNA Vaccines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the DNA Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of DNA Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of DNA Vaccines
1.2 Key Market Segments
1.2.1 DNA Vaccines Segment by Type
1.2.2 DNA Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DNA VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global DNA Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global DNA Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DNA VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global DNA Vaccines Product Life Cycle
3.3 Global DNA Vaccines Sales by Manufacturers (2020-2025)
3.4 Global DNA Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 DNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global DNA Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 DNA Vaccines Market Competitive Situation and Trends
3.8.1 DNA Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest DNA Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 DNA VACCINES INDUSTRY CHAIN ANALYSIS
4.1 DNA Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DNA VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global DNA Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to DNA Vaccines Market
5.7 ESG Ratings of Leading Companies
6 DNA VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global DNA Vaccines Sales Market Share by Type (2020-2025)
6.3 Global DNA Vaccines Market Size by Type (2020-2025)
6.4 Global DNA Vaccines Price by Type (2020-2025)
7 DNA VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global DNA Vaccines Market Sales by Application (2020-2025)
7.3 Global DNA Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global DNA Vaccines Sales Growth Rate by Application (2020-2025)
8 DNA VACCINES MARKET SALES BY REGION
8.1 Global DNA Vaccines Sales by Region
8.1.1 Global DNA Vaccines Sales by Region
8.1.2 Global DNA Vaccines Sales Market Share by Region
8.2 Global DNA Vaccines Market Size by Region
8.2.1 Global DNA Vaccines Market Size by Region
8.2.2 Global DNA Vaccines Market Size by Region
8.3 North America
8.3.1 North America DNA Vaccines Sales by Country
8.3.2 North America DNA Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe DNA Vaccines Sales by Country
8.4.2 Europe DNA Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific DNA Vaccines Sales by Region
8.5.2 Asia Pacific DNA Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America DNA Vaccines Sales by Country
8.6.2 South America DNA Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa DNA Vaccines Sales by Region
8.7.2 Middle East and Africa DNA Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 DNA VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of DNA Vaccines by Region(2020-2025)
9.2 Global DNA Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global DNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America DNA Vaccines Production
9.4.1 North America DNA Vaccines Production Growth Rate (2020-2025)
9.4.2 North America DNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe DNA Vaccines Production
9.5.1 Europe DNA Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe DNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan DNA Vaccines Production (2020-2025)
9.6.1 Japan DNA Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan DNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China DNA Vaccines Production (2020-2025)
9.7.1 China DNA Vaccines Production Growth Rate (2020-2025)
9.7.2 China DNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck DNA Vaccines Product Overview
10.1.3 Merck DNA Vaccines Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK DNA Vaccines Product Overview
10.2.3 GSK DNA Vaccines Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Sanofi
10.3.1 Sanofi Basic Information
10.3.2 Sanofi DNA Vaccines Product Overview
10.3.3 Sanofi DNA Vaccines Product Market Performance
10.3.4 Sanofi Business Overview
10.3.5 Sanofi SWOT Analysis
10.3.6 Sanofi Recent Developments
10.4 Zoties
10.4.1 Zoties Basic Information
10.4.2 Zoties DNA Vaccines Product Overview
10.4.3 Zoties DNA Vaccines Product Market Performance
10.4.4 Zoties Business Overview
10.4.5 Zoties Recent Developments
10.5 Elanco
10.5.1 Elanco Basic Information
10.5.2 Elanco DNA Vaccines Product Overview
10.5.3 Elanco DNA Vaccines Product Market Performance
10.5.4 Elanco Business Overview
10.5.5 Elanco Recent Developments
10.6 Boehringer-Ingelheim
10.6.1 Boehringer-Ingelheim Basic Information
10.6.2 Boehringer-Ingelheim DNA Vaccines Product Overview
10.6.3 Boehringer-Ingelheim DNA Vaccines Product Market Performance
10.6.4 Boehringer-Ingelheim Business Overview
10.6.5 Boehringer-Ingelheim Recent Developments
10.7 Indian Immunologicals
10.7.1 Indian Immunologicals Basic Information
10.7.2 Indian Immunologicals DNA Vaccines Product Overview
10.7.3 Indian Immunologicals DNA Vaccines Product Market Performance
10.7.4 Indian Immunologicals Business Overview
10.7.5 Indian Immunologicals Recent Developments
10.8 Plumbline Life Sciences
10.8.1 Plumbline Life Sciences Basic Information
10.8.2 Plumbline Life Sciences DNA Vaccines Product Overview
10.8.3 Plumbline Life Sciences DNA Vaccines Product Market Performance
10.8.4 Plumbline Life Sciences Business Overview
10.8.5 Plumbline Life Sciences Recent Developments
11 DNA VACCINES MARKET FORECAST BY REGION
11.1 Global DNA Vaccines Market Size Forecast
11.2 Global DNA Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe DNA Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific DNA Vaccines Market Size Forecast by Region
11.2.4 South America DNA Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of DNA Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global DNA Vaccines Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of DNA Vaccines by Type (2026-2035)
12.1.2 Global DNA Vaccines Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of DNA Vaccines by Type (2026-2035)
12.2 Global DNA Vaccines Market Forecast by Application (2026-2035)
12.2.1 Global DNA Vaccines Sales (K MT) Forecast by Application
12.2.2 Global DNA Vaccines Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of DNA Vaccines
1.2 Key Market Segments
1.2.1 DNA Vaccines Segment by Type
1.2.2 DNA Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DNA VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global DNA Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global DNA Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DNA VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global DNA Vaccines Product Life Cycle
3.3 Global DNA Vaccines Sales by Manufacturers (2020-2025)
3.4 Global DNA Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 DNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global DNA Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 DNA Vaccines Market Competitive Situation and Trends
3.8.1 DNA Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest DNA Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 DNA VACCINES INDUSTRY CHAIN ANALYSIS
4.1 DNA Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DNA VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global DNA Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to DNA Vaccines Market
5.7 ESG Ratings of Leading Companies
6 DNA VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global DNA Vaccines Sales Market Share by Type (2020-2025)
6.3 Global DNA Vaccines Market Size by Type (2020-2025)
6.4 Global DNA Vaccines Price by Type (2020-2025)
7 DNA VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global DNA Vaccines Market Sales by Application (2020-2025)
7.3 Global DNA Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global DNA Vaccines Sales Growth Rate by Application (2020-2025)
8 DNA VACCINES MARKET SALES BY REGION
8.1 Global DNA Vaccines Sales by Region
8.1.1 Global DNA Vaccines Sales by Region
8.1.2 Global DNA Vaccines Sales Market Share by Region
8.2 Global DNA Vaccines Market Size by Region
8.2.1 Global DNA Vaccines Market Size by Region
8.2.2 Global DNA Vaccines Market Size by Region
8.3 North America
8.3.1 North America DNA Vaccines Sales by Country
8.3.2 North America DNA Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe DNA Vaccines Sales by Country
8.4.2 Europe DNA Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific DNA Vaccines Sales by Region
8.5.2 Asia Pacific DNA Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America DNA Vaccines Sales by Country
8.6.2 South America DNA Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa DNA Vaccines Sales by Region
8.7.2 Middle East and Africa DNA Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 DNA VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of DNA Vaccines by Region(2020-2025)
9.2 Global DNA Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global DNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America DNA Vaccines Production
9.4.1 North America DNA Vaccines Production Growth Rate (2020-2025)
9.4.2 North America DNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe DNA Vaccines Production
9.5.1 Europe DNA Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe DNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan DNA Vaccines Production (2020-2025)
9.6.1 Japan DNA Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan DNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China DNA Vaccines Production (2020-2025)
9.7.1 China DNA Vaccines Production Growth Rate (2020-2025)
9.7.2 China DNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck DNA Vaccines Product Overview
10.1.3 Merck DNA Vaccines Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK DNA Vaccines Product Overview
10.2.3 GSK DNA Vaccines Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Sanofi
10.3.1 Sanofi Basic Information
10.3.2 Sanofi DNA Vaccines Product Overview
10.3.3 Sanofi DNA Vaccines Product Market Performance
10.3.4 Sanofi Business Overview
10.3.5 Sanofi SWOT Analysis
10.3.6 Sanofi Recent Developments
10.4 Zoties
10.4.1 Zoties Basic Information
10.4.2 Zoties DNA Vaccines Product Overview
10.4.3 Zoties DNA Vaccines Product Market Performance
10.4.4 Zoties Business Overview
10.4.5 Zoties Recent Developments
10.5 Elanco
10.5.1 Elanco Basic Information
10.5.2 Elanco DNA Vaccines Product Overview
10.5.3 Elanco DNA Vaccines Product Market Performance
10.5.4 Elanco Business Overview
10.5.5 Elanco Recent Developments
10.6 Boehringer-Ingelheim
10.6.1 Boehringer-Ingelheim Basic Information
10.6.2 Boehringer-Ingelheim DNA Vaccines Product Overview
10.6.3 Boehringer-Ingelheim DNA Vaccines Product Market Performance
10.6.4 Boehringer-Ingelheim Business Overview
10.6.5 Boehringer-Ingelheim Recent Developments
10.7 Indian Immunologicals
10.7.1 Indian Immunologicals Basic Information
10.7.2 Indian Immunologicals DNA Vaccines Product Overview
10.7.3 Indian Immunologicals DNA Vaccines Product Market Performance
10.7.4 Indian Immunologicals Business Overview
10.7.5 Indian Immunologicals Recent Developments
10.8 Plumbline Life Sciences
10.8.1 Plumbline Life Sciences Basic Information
10.8.2 Plumbline Life Sciences DNA Vaccines Product Overview
10.8.3 Plumbline Life Sciences DNA Vaccines Product Market Performance
10.8.4 Plumbline Life Sciences Business Overview
10.8.5 Plumbline Life Sciences Recent Developments
11 DNA VACCINES MARKET FORECAST BY REGION
11.1 Global DNA Vaccines Market Size Forecast
11.2 Global DNA Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe DNA Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific DNA Vaccines Market Size Forecast by Region
11.2.4 South America DNA Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of DNA Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global DNA Vaccines Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of DNA Vaccines by Type (2026-2035)
12.1.2 Global DNA Vaccines Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of DNA Vaccines by Type (2026-2035)
12.2 Global DNA Vaccines Market Forecast by Application (2026-2035)
12.2.1 Global DNA Vaccines Sales (K MT) Forecast by Application
12.2.2 Global DNA Vaccines Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global DNA Vaccines Market Size by Type (M USD)
Table 4. Global DNA Vaccines Market Size by Application
Table 5. DNA Vaccines Market Size Comparison by Region (M USD)
Table 6. Global DNA Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global DNA Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global DNA Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global DNA Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Vaccines as of 2025)
Table 11. Global Market DNA Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global DNA Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. DNA Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global DNA Vaccines Sales by Type (K MT)
Table 27. Global DNA Vaccines Market Size by Type (M USD)
Table 28. Global DNA Vaccines Sales (K MT) by Type (2020-2025)
Table 29. Global DNA Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global DNA Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global DNA Vaccines Market Share by Type (2020-2025)
Table 32. Global DNA Vaccines Price (USD/KG) by Type (2020-2025)
Table 33. Global DNA Vaccines Sales (K MT) by Application
Table 34. Global DNA Vaccines Market Size by Application
Table 35. Global DNA Vaccines Sales by Application (2020-2025) & (K MT)
Table 36. Global DNA Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global DNA Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global DNA Vaccines Market Share by Application (2020-2025)
Table 39. Global DNA Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global DNA Vaccines Sales by Region (2020-2025) & (K MT)
Table 41. Global DNA Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global DNA Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global DNA Vaccines Market Size by Region (2020-2025)
Table 44. North America DNA Vaccines Sales by Country (2020-2025) & (K MT)
Table 45. North America DNA Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe DNA Vaccines Sales by Country (2020-2025) & (K MT)
Table 47. Europe DNA Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific DNA Vaccines Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific DNA Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America DNA Vaccines Sales by Country (2020-2025) & (K MT)
Table 51. South America DNA Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa DNA Vaccines Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa DNA Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global DNA Vaccines Production (K MT) by Region(2020-2025)
Table 55. Global DNA Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global DNA Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global DNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America DNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe DNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan DNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China DNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merck Basic Information
Table 63. Merck DNA Vaccines Product Overview
Table 64. Merck DNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merck Business Overview
Table 66. Merck SWOT Analysis
Table 67. Merck Recent Developments
Table 68. GSK Basic Information
Table 69. GSK DNA Vaccines Product Overview
Table 70. GSK DNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Sanofi Basic Information
Table 75. Sanofi DNA Vaccines Product Overview
Table 76. Sanofi DNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sanofi Business Overview
Table 78. Sanofi SWOT Analysis
Table 79. Sanofi Recent Developments
Table 80. Zoties Basic Information
Table 81. Zoties DNA Vaccines Product Overview
Table 82. Zoties DNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Zoties Business Overview
Table 84. Zoties Recent Developments
Table 85. Elanco Basic Information
Table 86. Elanco DNA Vaccines Product Overview
Table 87. Elanco DNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Elanco Business Overview
Table 89. Elanco Recent Developments
Table 90. Boehringer-Ingelheim Basic Information
Table 91. Boehringer-Ingelheim DNA Vaccines Product Overview
Table 92. Boehringer-Ingelheim DNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Boehringer-Ingelheim Business Overview
Table 94. Boehringer-Ingelheim Recent Developments
Table 95. Indian Immunologicals Basic Information
Table 96. Indian Immunologicals DNA Vaccines Product Overview
Table 97. Indian Immunologicals DNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Indian Immunologicals Business Overview
Table 99. Indian Immunologicals Recent Developments
Table 100. Plumbline Life Sciences Basic Information
Table 101. Plumbline Life Sciences DNA Vaccines Product Overview
Table 102. Plumbline Life Sciences DNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Plumbline Life Sciences Business Overview
Table 104. Plumbline Life Sciences Recent Developments
Table 105. Global DNA Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global DNA Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America DNA Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America DNA Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe DNA Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe DNA Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific DNA Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific DNA Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America DNA Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America DNA Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa DNA Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa DNA Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global DNA Vaccines Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global DNA Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global DNA Vaccines Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global DNA Vaccines Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global DNA Vaccines Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global DNA Vaccines Market Size by Type (M USD)
Table 4. Global DNA Vaccines Market Size by Application
Table 5. DNA Vaccines Market Size Comparison by Region (M USD)
Table 6. Global DNA Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global DNA Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global DNA Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global DNA Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Vaccines as of 2025)
Table 11. Global Market DNA Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global DNA Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. DNA Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global DNA Vaccines Sales by Type (K MT)
Table 27. Global DNA Vaccines Market Size by Type (M USD)
Table 28. Global DNA Vaccines Sales (K MT) by Type (2020-2025)
Table 29. Global DNA Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global DNA Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global DNA Vaccines Market Share by Type (2020-2025)
Table 32. Global DNA Vaccines Price (USD/KG) by Type (2020-2025)
Table 33. Global DNA Vaccines Sales (K MT) by Application
Table 34. Global DNA Vaccines Market Size by Application
Table 35. Global DNA Vaccines Sales by Application (2020-2025) & (K MT)
Table 36. Global DNA Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global DNA Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global DNA Vaccines Market Share by Application (2020-2025)
Table 39. Global DNA Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global DNA Vaccines Sales by Region (2020-2025) & (K MT)
Table 41. Global DNA Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global DNA Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global DNA Vaccines Market Size by Region (2020-2025)
Table 44. North America DNA Vaccines Sales by Country (2020-2025) & (K MT)
Table 45. North America DNA Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe DNA Vaccines Sales by Country (2020-2025) & (K MT)
Table 47. Europe DNA Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific DNA Vaccines Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific DNA Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America DNA Vaccines Sales by Country (2020-2025) & (K MT)
Table 51. South America DNA Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa DNA Vaccines Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa DNA Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global DNA Vaccines Production (K MT) by Region(2020-2025)
Table 55. Global DNA Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global DNA Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global DNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America DNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe DNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan DNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China DNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merck Basic Information
Table 63. Merck DNA Vaccines Product Overview
Table 64. Merck DNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merck Business Overview
Table 66. Merck SWOT Analysis
Table 67. Merck Recent Developments
Table 68. GSK Basic Information
Table 69. GSK DNA Vaccines Product Overview
Table 70. GSK DNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Sanofi Basic Information
Table 75. Sanofi DNA Vaccines Product Overview
Table 76. Sanofi DNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sanofi Business Overview
Table 78. Sanofi SWOT Analysis
Table 79. Sanofi Recent Developments
Table 80. Zoties Basic Information
Table 81. Zoties DNA Vaccines Product Overview
Table 82. Zoties DNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Zoties Business Overview
Table 84. Zoties Recent Developments
Table 85. Elanco Basic Information
Table 86. Elanco DNA Vaccines Product Overview
Table 87. Elanco DNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Elanco Business Overview
Table 89. Elanco Recent Developments
Table 90. Boehringer-Ingelheim Basic Information
Table 91. Boehringer-Ingelheim DNA Vaccines Product Overview
Table 92. Boehringer-Ingelheim DNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Boehringer-Ingelheim Business Overview
Table 94. Boehringer-Ingelheim Recent Developments
Table 95. Indian Immunologicals Basic Information
Table 96. Indian Immunologicals DNA Vaccines Product Overview
Table 97. Indian Immunologicals DNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Indian Immunologicals Business Overview
Table 99. Indian Immunologicals Recent Developments
Table 100. Plumbline Life Sciences Basic Information
Table 101. Plumbline Life Sciences DNA Vaccines Product Overview
Table 102. Plumbline Life Sciences DNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Plumbline Life Sciences Business Overview
Table 104. Plumbline Life Sciences Recent Developments
Table 105. Global DNA Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global DNA Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America DNA Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America DNA Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe DNA Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe DNA Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific DNA Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific DNA Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America DNA Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America DNA Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa DNA Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa DNA Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global DNA Vaccines Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global DNA Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global DNA Vaccines Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global DNA Vaccines Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global DNA Vaccines Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of DNA Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global DNA Vaccines Market Size (M USD), 2025-2035
Figure 5. Global DNA Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global DNA Vaccines Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. DNA Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global DNA Vaccines Product Life Cycle
Figure 13. DNA Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global DNA Vaccines Revenue Share by Manufacturers in 2025
Figure 15. DNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market DNA Vaccines Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by DNA Vaccines Revenue in 2025
Figure 18. Industry Chain Map of DNA Vaccines
Figure 19. Global DNA Vaccines Market PEST Analysis
Figure 20. Global DNA Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global DNA Vaccines Market Share by Type
Figure 27. Sales Market Share of DNA Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of DNA Vaccines by Type in 2025
Figure 29. Market Share of DNA Vaccines by Type (2020-2025)
Figure 30. Market Share of DNA Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global DNA Vaccines Market Share by Application
Figure 33. Global DNA Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global DNA Vaccines Sales Market Share by Application in 2025
Figure 35. Global DNA Vaccines Market Share by Application (2020-2025)
Figure 36. Global DNA Vaccines Market Share by Application in 2025
Figure 37. Global DNA Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global DNA Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global DNA Vaccines Market Size by Region (2020-2025)
Figure 40. North America DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America DNA Vaccines Sales Market Share by Country in 2024
Figure 43. North America DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America DNA Vaccines Market Size by Country in 2024
Figure 45. U.S. DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada DNA Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada DNA Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico DNA Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico DNA Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe DNA Vaccines Sales Market Share by Country in 2024
Figure 53. Europe DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe DNA Vaccines Market Size by Country in 2024
Figure 55. Germany DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific DNA Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific DNA Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific DNA Vaccines Market Size by Region in 2024
Figure 68. China DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America DNA Vaccines Sales and Growth Rate (K MT)
Figure 79. South America DNA Vaccines Sales Market Share by Country in 2024
Figure 80. South America DNA Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America DNA Vaccines Market Size by Country in 2024
Figure 82. Brazil DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa DNA Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa DNA Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa DNA Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa DNA Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global DNA Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America DNA Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe DNA Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan DNA Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China DNA Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global DNA Vaccines Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global DNA Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global DNA Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global DNA Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global DNA Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global DNA Vaccines Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of DNA Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global DNA Vaccines Market Size (M USD), 2025-2035
Figure 5. Global DNA Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global DNA Vaccines Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. DNA Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global DNA Vaccines Product Life Cycle
Figure 13. DNA Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global DNA Vaccines Revenue Share by Manufacturers in 2025
Figure 15. DNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market DNA Vaccines Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by DNA Vaccines Revenue in 2025
Figure 18. Industry Chain Map of DNA Vaccines
Figure 19. Global DNA Vaccines Market PEST Analysis
Figure 20. Global DNA Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global DNA Vaccines Market Share by Type
Figure 27. Sales Market Share of DNA Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of DNA Vaccines by Type in 2025
Figure 29. Market Share of DNA Vaccines by Type (2020-2025)
Figure 30. Market Share of DNA Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global DNA Vaccines Market Share by Application
Figure 33. Global DNA Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global DNA Vaccines Sales Market Share by Application in 2025
Figure 35. Global DNA Vaccines Market Share by Application (2020-2025)
Figure 36. Global DNA Vaccines Market Share by Application in 2025
Figure 37. Global DNA Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global DNA Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global DNA Vaccines Market Size by Region (2020-2025)
Figure 40. North America DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America DNA Vaccines Sales Market Share by Country in 2024
Figure 43. North America DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America DNA Vaccines Market Size by Country in 2024
Figure 45. U.S. DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada DNA Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada DNA Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico DNA Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico DNA Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe DNA Vaccines Sales Market Share by Country in 2024
Figure 53. Europe DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe DNA Vaccines Market Size by Country in 2024
Figure 55. Germany DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific DNA Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific DNA Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific DNA Vaccines Market Size by Region in 2024
Figure 68. China DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America DNA Vaccines Sales and Growth Rate (K MT)
Figure 79. South America DNA Vaccines Sales Market Share by Country in 2024
Figure 80. South America DNA Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America DNA Vaccines Market Size by Country in 2024
Figure 82. Brazil DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa DNA Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa DNA Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa DNA Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa DNA Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa DNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa DNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global DNA Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America DNA Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe DNA Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan DNA Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China DNA Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global DNA Vaccines Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global DNA Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global DNA Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global DNA Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global DNA Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global DNA Vaccines Market Share Forecast by Application (2026-2035)
